Aug 30, 2026
U.S. Anti-Dandruff Shampoo for Textured Hair: Active Ingredients, Labeling and OEM Documents
A buyer-focused guide to developing moisturizing anti-dandruff shampoo for textured hair while addressing U.S. active ingredients, Drug Facts and documentation.
U.S. Anti-Dandruff Shampoo for Textured Hair: Active Ingredients, Labeling and OEM Documents
A moisturizing anti-dandruff shampoo for textured hair must solve two different problems: regulatory compliance and consumer performance. In the United States, an anti-dandruff shampoo is an OTC drug product. It cannot be managed as an ordinary cosmetic shampoo with a dandruff marketing claim added later.
Regulatory Starting Point
The brand and manufacturer must confirm that the active ingredient, concentration, indications, warnings, directions and Drug Facts labeling follow the applicable U.S. OTC requirements. Formula review must cover both active and inactive ingredients, manufacturing controls and the final market presentation.
Active Ingredient Selection
Common anti-dandruff routes may include ingredients permitted under the applicable monograph or another legally supported pathway. Selection should consider scalp condition, cleansing system, hair feel, compatibility, color, odor, stability and supply documentation.
The exact active ingredient and concentration must be confirmed for the intended U.S. product. A supplier specification alone does not replace finished-product development, manufacturing and regulatory review.
Performance for 4A–4C Hair
Textured hair consumers may avoid frequent dandruff shampoo use when the formula leaves lengths rough or difficult to detangle. A better development brief should address:
• Effective scalp cleansing
• Controlled deposition of the active system
• Reduced stripped or squeaky after-feel
• Improved wet-combing slip
• Compatibility with protective styles
• Fragrance and residue appropriate for repeat use
Conditioning ingredients, humectants and mild surfactant choices can improve the cosmetic experience, but they must remain compatible with the active ingredient and stability requirements.
Required Label and Documents
The buyer should plan for Drug Facts, full inactive-ingredient disclosure, directions, warnings, net contents, responsible company information, batch coding and other applicable information.
Depending on the project scope, supporting files may include GMP or ISO 22716 certificates, formula specification, COA, SDS, microbiological results, stability data and packaging compatibility records. Drug-product requirements may require additional documentation and services beyond a standard private-label cosmetic order.
Low-MOQ Reality
A mature cosmetic shampoo can often start at 100 pieces with stock packaging. A compliant U.S. OTC anti-dandruff project may require a higher technical budget even if the physical quantity is small. Regulatory work, testing and documentation do not decrease in proportion to bottle quantity.
FAQ
Can an existing cosmetic shampoo simply add an anti-dandruff claim?
No. The formula, active ingredient, labeling, manufacturing route and documentation must support the U.S. OTC drug requirements.
Can the formula still be moisturizing?
Yes. The inactive system can be designed for better softness, slip and manageability, subject to compatibility with the active.
Can the sample be tested before bulk production?
Yes. Prototype sampling should evaluate scalp cleansing, hair feel, fragrance, residue and packaging before the production decision.
Can a factory provide all regulatory documents immediately?
Standard factory certificates can be shared for supplier evaluation. Product-specific files are normally tied to the approved formula, order, testing and regulatory scope.
What is the safest buyer next step?
Confirm the target market, active route, product claims, pack size, quantity and regulatory responsibility before requesting a final quotation.
